Table 2 Evaluation of the extraction recovery, matrix effect, and precision in the UPLC-MS/MS analysis of standard mixtures of DSV, TAM, and TOH with OND (IS).

From: Development and validation of UPLC-MS/MS method for studying the pharmacokinetic interaction of dasabuvir and tamoxifen, 4-hydroxytamoxifen in Wistar rats

 

Concentration spiked (ng/ml)

Extraction recovery

Matrix effect

Precision

Intra-day

(n = 6)

Inter-day (n = 18)

Mean recovery (%) ± RSDa

Er(%)b

Mean recovery (%) ±RSDa

Er(%)b

Mean recovery (%) ±RSDa

Er(%)b

Mean recovery (%) ±RSDa

Er(%)b

DSV

20

96.37 ± 1.66

−3.63

97.78 ± 2.32

−2.22

98.60 ± 1.19

−1.40

97.43 ± 2.06

−2.57

60

97.05 ± 1.59

−2.95

97.28 ± 2.45

−2.72

97.22 ± 1.92

−2.78

98.65 ± 1.89

−1.35

500

96.30 ± 1.47

−3.70

93.65 ± 4.56

−6.35

98.21 ± 1.95

−1.79

98.12 ± 0.66

−1.88

800

90.11 ± 6.38

−9.89

99.32 ± 1.85

−0.68

97.67 ± 2.17

−2.33

97.77 ± 1.03

−2.23

TAM

0.1

95.05 ± 2.51

−4.95

96.21 ± 1.32

−3.79

95.58 ± 3.28

−4.42

93.70 ± 2.24

−6.30

0.3

97.40 ± 2.47

−2.60

96.66 ± 1.83

−3.34

98.57 ± 0.79

1.43

97.89 ± 1.52

−2.11

100

96.48 ± 1.12

−3.52

92.26 ± 3.01

−7.74

99.07 ± 3.98

−0.93

99.13 ± 0.76

−0.87

400

89.01 ± 7.88

−10.99

98.89 ± 7.54

−1.11

98.47 ± 2.44

−1.53

98.77 ± 1.75

−1.23

TOH

0.5

101.68 ± 2.33

1.68

97.96 ± 0.99

−2.04

99.95 ± 3.04

−0.05

98.08 ± 1.43

−1.92

1.5

95.82 ± 5.65

−4.18

97.73 ± 1.28

−2.27

99.41 ± 2.04

−0.59

99.65 ± 1.74

−0.35

150

99.78 ± 0.99

−0.22

99.02 ± 2.44

−0.98

96.36 ± 3.05

−3.64

98.80 ± 1.57

−1.20

400

91.95 ± 3.21

−8.05

101.45 ± 2.78

1.45

98.01 ± 2.02

−1.99

97.25 ± 2.61

−2.75

  1. aMean recovery (%) ± RSD of six determinations.
  2. bPercentage relative error.